3-amino-1,2,4-benzotriazine-1-oxide and Breast Neoplasms

3-amino-1,2,4-benzotriazine-1-oxide has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, GE; Barham, HM; Chinje, EC; Harris, AL; Patterson, AV; Stratford, IJ	1

Other Studies

1 other study(ies) available for 3-amino-1,2,4-benzotriazine-1-oxide and Breast Neoplasms

Article	Year
Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233). British journal of cancer, 1995, Volume: 72, Issue:5 Topics: Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Hypoxia; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Humans; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Oxidoreductases; Oxygen; Prodrugs; Tirapazamine; Triazines; Tumor Cells, Cultured	1995

Article

Year

Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).

British journal of cancer, 1995, Volume: 72, Issue:5

Topics: Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Hypoxia; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Humans; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Oxidoreductases; Oxygen; Prodrugs; Tirapazamine; Triazines; Tumor Cells, Cultured

1995